# FDA Inspection 1314816 - Biolife Plasma Services L.P. - April 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/21b385f3-7b04-4a64-b19d-e78feabf08b2
Source feed: FDA_Inspections

> FDA Inspection 1314816 for Biolife Plasma Services L.P. on April 28, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314816
- Company Name: Biolife Plasma Services L.P.
- Inspection Date: 2026-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162485 - 2022-02-08](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/3858a3d4-156d-4132-9c84-fe96e0190369)
- [FDA Inspection 1162485 - 2022-02-08](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/5c7dbc57-2e4c-4525-9570-58a802b87bc7)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/4f3c376b-daee-4779-a585-d31dc23d84bd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d